WallStreetZenWallStreetZen

NASDAQ: NYMX
Nymox Pharmaceutical Corp Stock

Open Broker Account
$0.42+0.05 (+13.51%)
Updated Sep 30, 2022
NYMX Price
$0.42
Fair Value Price
$0.42
Market Cap
$37.47M
52 Week Low
$0.19
52 Week High
$2.15
P/E
-3.46x
P/B
16.79x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$9.85M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
1
Operating Cash Flow
-$8M
Beta
0.8
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NYMX Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NYMX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NYMX ($0.42) is undervalued by 1.78% relative to our estimate of its Fair Value price of $0.42 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NYMX ($0.42) is not significantly undervalued (1.78%) relative to our estimate of its Fair Value price of $0.42 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NYMX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NYMX due diligence checks available for Premium users.

Be the first to know about important NYMX news, forecast changes, insider trades & much more!

NYMX News

Valuation

NYMX fair value

Fair Value of NYMX stock based on Discounted Cash Flow (DCF)
Price
$0.42
Fair Value
$0.42
Undervalued by
0.59%
NYMX ($0.42) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NYMX ($0.42) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NYMX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NYMX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.46x
Industry
14.28x
Market
27.64x

NYMX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
16.79x
Industry
4.39x
NYMX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NYMX's financial health

Profit margin

Revenue
$0.0
Net Income
$1.3M
Profit Margin
0%
NYMX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$4.5M
Liabilities
$2.2M
Debt to equity
1
NYMX's short-term assets ($4.19M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NYMX's short-term assets ($4.19M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NYMX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NYMX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$1.6M
Investing
$0.0
Financing
$1.8M
NYMX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NYMX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NYMX$37.47M+13.70%-3.46x16.79x
RFL$37.45M0.00%-0.26x0.38x
CYCN$37.39M-5.49%-0.77x1.47x
IBIO$37.09M-6.59%-1.13x0.47x
AMTI$37.85M-0.71%-0.28x0.39x

Nymox Pharmaceutical Stock FAQ

What is Nymox Pharmaceutical's quote symbol?

NASDAQ: NYMX) Nymox Pharmaceutical trades on the NASDAQ under the ticker symbol NYMX. Nymox Pharmaceutical stock quotes can also be displayed as NASDAQ: NYMX.

If you're new to stock investing, here's how to buy Nymox Pharmaceutical stock.

What is the 52 week high and low for Nymox Pharmaceutical (NASDAQ: NYMX)?

(NASDAQ: NYMX) Nymox Pharmaceutical's 52-week high was $2.15, and its 52-week low was $0.19. It is currently -80.7% from its 52-week high and 124.32% from its 52-week low.

How much is Nymox Pharmaceutical stock worth today?

(NASDAQ: NYMX) Nymox Pharmaceutical currently has 90,280,000 outstanding shares. With Nymox Pharmaceutical stock trading at $0.42 per share, the total value of Nymox Pharmaceutical stock (market capitalization) is $37.47M.

Nymox Pharmaceutical stock was originally listed at a price of $6.75 in Dec 31, 1997. If you had invested in Nymox Pharmaceutical stock at $6.75, your return over the last 24 years would have been -93.85%, for an annualized return of -10.97% (not including any dividends or dividend reinvestments).

How much is Nymox Pharmaceutical's stock price per share?

(NASDAQ: NYMX) Nymox Pharmaceutical stock price per share is $0.42 today (as of Sep 30, 2022).

What is Nymox Pharmaceutical's Market Cap?

(NASDAQ: NYMX) Nymox Pharmaceutical's market cap is $37.47M, as of Oct 2, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nymox Pharmaceutical's market cap is calculated by multiplying NYMX's current stock price of $0.42 by NYMX's total outstanding shares of 90,280,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.